Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of MS-20 on Gut Microbiota in Healthy Adults
NCT04674839Completed
- Sponsor
- Microbio Co., Ltd.
- Start
- Oct 2019
- Primary completion
- Sep 2020
- Modality
- Complex Communities
- Countries
- 1
01
Overview
Randomised, double-blind trial in cancer-related fatigue (CRF) and anorexia nervosa (AN) comparing MS-20 with Placebo (2 arms). Primary endpoint: Change in Gut microbiota composition from baseline at 8 weeks. Started Oct 2019; status: completed.
02
Drugs
MicrSoy-20
03
Conditions
cancer-related fatigue (CRF)anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT04674839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04674839.